Nanomaterials (Basel), 2019, 9(9)

Nanoencapsulation Enhances Anticoagulant Activity of Adenosine and Dipeptide IleTrp.

It is well-known that drugs administered into an organism intravenously or through the gastrointestinal tract are degraded by enzymes of the body, reducing their therapeutic effect. One of the ways to decrease this undesirable process is through the inclusion of drugs in nanomaterials. Earlier strong anticoagulant activity was demonstrated for dipeptide IleTrp (IW) and adenosine (Ado). In this work, the effect of inclusion in nanomaterials on the biological activity of IW and Ado was studied. For this purpose, Ado and IW were incorporated into thermosensitive nanogel composed of pluronic P123-grafted heparin. The prepared nanocarrier was characterized by transmission electron microscopy, dynamic light scattering, and ζ-potential. Biological activity was determined by measuring the bleeding time from mouse tail in vivo and the time of clot formation in vitro. It was found that encapsulation of Ado and IW into nanomaterial significantly increased their effects, resulting in an increase in the bleeding time from mouse tail and clot formation time. Thus, inclusion of low molecular weight anticoagulants Ado and IW into nanomaterials may be considered a way to increase their biological activity.

Nguyen TD, Nguyen TN, Nguyen TTT, Ivanov IA, Nguyen KC, Tran QN, Hoang AN, Utkin YN

IBCH: 8107
Ссылка на статью в журнале: https://www.mdpi.com/2079-4991/9/9/1191
Нет данных о цитировании
Данные статьи проверены модераторами 2019-08-26